{"transactions":[{"id":2256499,"issuer":{"id":2172,"kind":"organization","name":"10x Genomics, Inc.","symbol":"TXG"},"owners":[{"id":124251,"kind":"person","name":"CRUTCHFIELD BRADFORD","position":1,"cik":"0001246406","reported_name":"CRUTCHFIELD BRADFORD","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Commercial Officer"}}],"security":"Class A Common Stock","published_at":"2022-05-25T18:28:46.000Z","date":"2022-05-23","kind":"sale","acquired":false,"shares":286,"price":48.7642,"value":13946.5612,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The shares were sold to cover tax withholding obligations in connection with the vesting of restricted stock units."}],"balance_after":97237,"source":{"system":"sec-edgar","filing":"0001567619-22-011711","document":"doc1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1246406/000156761922011711/doc1.xml","form_type":"4"}},{"id":2267708,"issuer":{"id":2172,"kind":"organization","name":"10x Genomics, Inc.","symbol":"TXG"},"owners":[{"id":124251,"kind":"person","name":"CRUTCHFIELD BRADFORD","position":1,"cik":"0001246406","reported_name":"CRUTCHFIELD BRADFORD","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Commercial Officer"}}],"security":"Class A Common Stock","published_at":"2022-05-17T17:25:54.000Z","date":"2022-05-13","kind":"purchase","acquired":true,"shares":158,"price":40.4855,"value":6396.709,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The purchase was made under the Issuer's 2019 Employee Stock Purchase Plan in a transaction exempt from Section 16(b) under Rule 16b-3(c)."}],"balance_after":97523,"source":{"system":"sec-edgar","filing":"0001567619-22-011119","document":"doc1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1246406/000156761922011119/doc1.xml","form_type":"4"}},{"id":2374407,"issuer":{"id":2172,"kind":"organization","name":"10x Genomics, Inc.","symbol":"TXG"},"owners":[{"id":124251,"kind":"person","name":"CRUTCHFIELD BRADFORD","position":1,"cik":"0001246406","reported_name":"CRUTCHFIELD BRADFORD","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Commercial Officer"}}],"security":"Class A Common Stock","published_at":"2022-02-24T19:37:57.000Z","date":"2022-02-22","kind":"sale","acquired":false,"shares":288,"price":78.5993,"value":22636.5984,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The shares were sold to cover tax withholding obligations in connection with the vesting of restricted stock units."}],"balance_after":97365,"source":{"system":"sec-edgar","filing":"0001567619-22-005519","document":"doc1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1246406/000156761922005519/doc1.xml","form_type":"4"}},{"id":2388094,"issuer":{"id":2172,"kind":"organization","name":"10x Genomics, Inc.","symbol":"TXG"},"owners":[{"id":124251,"kind":"person","name":"CRUTCHFIELD BRADFORD","position":1,"cik":"0001246406","reported_name":"CRUTCHFIELD BRADFORD","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Commercial Officer"}}],"security":"Stock Option (right to buy)","published_at":"2022-02-17T16:48:10.000Z","date":"2022-02-15","kind":"exercise","acquired":false,"shares":17000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The transactions reported herein were effected pursuant to the Reporting Person's Rule 10b5-1 trading plan."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"This option, originally for 800,000 shares, of which 408,000 shares have been exercised, vested as to one-fourth of the shares on February 2, 2018 and one forty-eighth of the shares subject to the option vest each month thereafter, subject to the Reporting Person continuing as a service provider through each such date."}],"balance_after":392000,"derivative":{"exercise_price":1.16,"expiration_date":"2027-02-03","underlying":"Class A Common Stock","underlying_shares":17000},"source":{"system":"sec-edgar","filing":"0001567619-22-004884","document":"doc1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1246406/000156761922004884/doc1.xml","form_type":"4"}},{"id":2388093,"issuer":{"id":2172,"kind":"organization","name":"10x Genomics, Inc.","symbol":"TXG"},"owners":[{"id":124251,"kind":"person","name":"CRUTCHFIELD BRADFORD","position":1,"cik":"0001246406","reported_name":"CRUTCHFIELD BRADFORD","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Commercial Officer"}}],"security":"Class A Common Stock","published_at":"2022-02-17T16:48:10.000Z","date":"2022-02-15","kind":"sale","acquired":false,"shares":17000,"price":95.133,"value":1617261.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The transactions reported herein were effected pursuant to the Reporting Person's Rule 10b5-1 trading plan."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"This transaction was executed in multiple trades at prices ranging from $95.00 to $95.38. The price reported above reflects the weighted average sale price. The Reporting Person undertakes to provide upon request by the staff of the Securities and Exchange Commission, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate sale price."}],"balance_after":97653,"source":{"system":"sec-edgar","filing":"0001567619-22-004884","document":"doc1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1246406/000156761922004884/doc1.xml","form_type":"4"}},{"id":2388092,"issuer":{"id":2172,"kind":"organization","name":"10x Genomics, Inc.","symbol":"TXG"},"owners":[{"id":124251,"kind":"person","name":"CRUTCHFIELD BRADFORD","position":1,"cik":"0001246406","reported_name":"CRUTCHFIELD BRADFORD","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Commercial Officer"}}],"security":"Class A Common Stock","published_at":"2022-02-17T16:48:10.000Z","date":"2022-02-15","kind":"exercise","acquired":true,"shares":17000,"price":1.16,"value":19720.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The transactions reported herein were effected pursuant to the Reporting Person's Rule 10b5-1 trading plan."}],"balance_after":114653,"source":{"system":"sec-edgar","filing":"0001567619-22-004884","document":"doc1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1246406/000156761922004884/doc1.xml","form_type":"4"}},{"id":2434742,"issuer":{"id":2172,"kind":"organization","name":"10x Genomics, Inc.","symbol":"TXG"},"owners":[{"id":124251,"kind":"person","name":"CRUTCHFIELD BRADFORD","position":1,"cik":"0001246406","reported_name":"CRUTCHFIELD BRADFORD","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Commercial Officer"}}],"security":"Stock Option (right to buy)","published_at":"2022-01-14T16:32:12.000Z","date":"2022-01-12","kind":"exercise","acquired":false,"shares":17000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The transactions reported herein were effected pursuant to the Reporting Person's Rule 10b5-1 trading plan."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F7","text":"This option, originally for 800,000 shares, of which 391,000 shares have been exercised, vested as to one-fourth of the shares on February 2, 2018 and one forty-eighth of the shares subject to the option vest each month thereafter, subject to the Reporting Person continuing as a service provider through each such date."}],"balance_after":409000,"derivative":{"exercise_price":1.16,"expiration_date":"2027-02-03","underlying":"Class A Common Stock","underlying_shares":17000},"source":{"system":"sec-edgar","filing":"0001567619-22-001197","document":"doc1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":11,"url":"https://www.sec.gov/Archives/edgar/data/1246406/000156761922001197/doc1.xml","form_type":"4"}},{"id":2434741,"issuer":{"id":2172,"kind":"organization","name":"10x Genomics, Inc.","symbol":"TXG"},"owners":[{"id":124251,"kind":"person","name":"CRUTCHFIELD BRADFORD","position":1,"cik":"0001246406","reported_name":"CRUTCHFIELD BRADFORD","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Commercial Officer"}}],"security":"Class A Common Stock","published_at":"2022-01-14T16:32:12.000Z","date":"2022-01-12","kind":"sale","acquired":false,"shares":3,"price":125,"value":375.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The transactions reported herein were effected pursuant to the Reporting Person's Rule 10b5-1 trading plan."}],"balance_after":97653,"source":{"system":"sec-edgar","filing":"0001567619-22-001197","document":"doc1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":10,"url":"https://www.sec.gov/Archives/edgar/data/1246406/000156761922001197/doc1.xml","form_type":"4"}},{"id":2434740,"issuer":{"id":2172,"kind":"organization","name":"10x Genomics, Inc.","symbol":"TXG"},"owners":[{"id":124251,"kind":"person","name":"CRUTCHFIELD BRADFORD","position":1,"cik":"0001246406","reported_name":"CRUTCHFIELD BRADFORD","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Commercial Officer"}}],"security":"Class A Common Stock","published_at":"2022-01-14T16:32:12.000Z","date":"2022-01-12","kind":"sale","acquired":false,"shares":100,"price":124.44,"value":12444.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The transactions reported herein were effected pursuant to the Reporting Person's Rule 10b5-1 trading plan."}],"balance_after":97656,"source":{"system":"sec-edgar","filing":"0001567619-22-001197","document":"doc1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":9,"url":"https://www.sec.gov/Archives/edgar/data/1246406/000156761922001197/doc1.xml","form_type":"4"}},{"id":2434739,"issuer":{"id":2172,"kind":"organization","name":"10x Genomics, Inc.","symbol":"TXG"},"owners":[{"id":124251,"kind":"person","name":"CRUTCHFIELD BRADFORD","position":1,"cik":"0001246406","reported_name":"CRUTCHFIELD BRADFORD","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Commercial Officer"}}],"security":"Class A Common Stock","published_at":"2022-01-14T16:32:12.000Z","date":"2022-01-12","kind":"sale","acquired":false,"shares":100,"price":123.53,"value":12353.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The transactions reported herein were effected pursuant to the Reporting Person's Rule 10b5-1 trading plan."}],"balance_after":97756,"source":{"system":"sec-edgar","filing":"0001567619-22-001197","document":"doc1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":8,"url":"https://www.sec.gov/Archives/edgar/data/1246406/000156761922001197/doc1.xml","form_type":"4"}},{"id":2434738,"issuer":{"id":2172,"kind":"organization","name":"10x Genomics, Inc.","symbol":"TXG"},"owners":[{"id":124251,"kind":"person","name":"CRUTCHFIELD BRADFORD","position":1,"cik":"0001246406","reported_name":"CRUTCHFIELD BRADFORD","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Commercial Officer"}}],"security":"Class A Common Stock","published_at":"2022-01-14T16:32:12.000Z","date":"2022-01-12","kind":"sale","acquired":false,"shares":100,"price":122.94,"value":12294.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The transactions reported herein were effected pursuant to the Reporting Person's Rule 10b5-1 trading plan."}],"balance_after":97856,"source":{"system":"sec-edgar","filing":"0001567619-22-001197","document":"doc1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":7,"url":"https://www.sec.gov/Archives/edgar/data/1246406/000156761922001197/doc1.xml","form_type":"4"}},{"id":2434737,"issuer":{"id":2172,"kind":"organization","name":"10x Genomics, Inc.","symbol":"TXG"},"owners":[{"id":124251,"kind":"person","name":"CRUTCHFIELD BRADFORD","position":1,"cik":"0001246406","reported_name":"CRUTCHFIELD BRADFORD","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Commercial Officer"}}],"security":"Class A Common Stock","published_at":"2022-01-14T16:32:12.000Z","date":"2022-01-12","kind":"sale","acquired":false,"shares":3200,"price":121.765,"value":389648.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The transactions reported herein were effected pursuant to the Reporting Person's Rule 10b5-1 trading plan."},{"field":"price","element":"transactionPricePerShare","label":"F6","text":"This transaction was executed in multiple trades at prices ranging from $121.47 to $122.35. The price reported above reflects the weighted average sale price. The Reporting Person undertakes to provide upon request by the staff of the Securities and Exchange Commission, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate sale price."}],"balance_after":97956,"source":{"system":"sec-edgar","filing":"0001567619-22-001197","document":"doc1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/1246406/000156761922001197/doc1.xml","form_type":"4"}},{"id":2434736,"issuer":{"id":2172,"kind":"organization","name":"10x Genomics, Inc.","symbol":"TXG"},"owners":[{"id":124251,"kind":"person","name":"CRUTCHFIELD BRADFORD","position":1,"cik":"0001246406","reported_name":"CRUTCHFIELD BRADFORD","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Commercial Officer"}}],"security":"Class A Common Stock","published_at":"2022-01-14T16:32:12.000Z","date":"2022-01-12","kind":"sale","acquired":false,"shares":1100,"price":120.9314,"value":133024.54,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The transactions reported herein were effected pursuant to the Reporting Person's Rule 10b5-1 trading plan."},{"field":"price","element":"transactionPricePerShare","label":"F5","text":"This transaction was executed in multiple trades at prices ranging from $120.31 to $121.29. The price reported above reflects the weighted average sale price. The Reporting Person undertakes to provide upon request by the staff of the Securities and Exchange Commission, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate sale price."}],"balance_after":101156,"source":{"system":"sec-edgar","filing":"0001567619-22-001197","document":"doc1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1246406/000156761922001197/doc1.xml","form_type":"4"}},{"id":2434735,"issuer":{"id":2172,"kind":"organization","name":"10x Genomics, Inc.","symbol":"TXG"},"owners":[{"id":124251,"kind":"person","name":"CRUTCHFIELD BRADFORD","position":1,"cik":"0001246406","reported_name":"CRUTCHFIELD BRADFORD","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Commercial Officer"}}],"security":"Class A Common Stock","published_at":"2022-01-14T16:32:12.000Z","date":"2022-01-12","kind":"sale","acquired":false,"shares":1017,"price":119.2834,"value":121311.2178,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The transactions reported herein were effected pursuant to the Reporting Person's Rule 10b5-1 trading plan."},{"field":"price","element":"transactionPricePerShare","label":"F4","text":"This transaction was executed in multiple trades at prices ranging from $118.985 to $119.83. The price reported above reflects the weighted average sale price. The Reporting Person undertakes to provide upon request by the staff of the Securities and Exchange Commission, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate sale price."}],"balance_after":102256,"source":{"system":"sec-edgar","filing":"0001567619-22-001197","document":"doc1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1246406/000156761922001197/doc1.xml","form_type":"4"}},{"id":2434734,"issuer":{"id":2172,"kind":"organization","name":"10x Genomics, Inc.","symbol":"TXG"},"owners":[{"id":124251,"kind":"person","name":"CRUTCHFIELD BRADFORD","position":1,"cik":"0001246406","reported_name":"CRUTCHFIELD BRADFORD","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Commercial Officer"}}],"security":"Class A Common Stock","published_at":"2022-01-14T16:32:12.000Z","date":"2022-01-12","kind":"sale","acquired":false,"shares":5185,"price":118.3218,"value":613498.533,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The transactions reported herein were effected pursuant to the Reporting Person's Rule 10b5-1 trading plan."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"This transaction was executed in multiple trades at prices ranging from $117.90 to $118.84. The price reported above reflects the weighted average sale price. The Reporting Person undertakes to provide upon request by the staff of the Securities and Exchange Commission, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate sale price."}],"balance_after":103273,"source":{"system":"sec-edgar","filing":"0001567619-22-001197","document":"doc1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1246406/000156761922001197/doc1.xml","form_type":"4"}},{"id":2434733,"issuer":{"id":2172,"kind":"organization","name":"10x Genomics, Inc.","symbol":"TXG"},"owners":[{"id":124251,"kind":"person","name":"CRUTCHFIELD BRADFORD","position":1,"cik":"0001246406","reported_name":"CRUTCHFIELD BRADFORD","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Commercial Officer"}}],"security":"Class A Common Stock","published_at":"2022-01-14T16:32:12.000Z","date":"2022-01-12","kind":"sale","acquired":false,"shares":6195,"price":117.5256,"value":728071.092,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The transactions reported herein were effected pursuant to the Reporting Person's Rule 10b5-1 trading plan."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"This transaction was executed in multiple trades at prices ranging from $116.89 to $117.87. The price reported above reflects the weighted average sale price. The Reporting Person undertakes to provide upon request by the staff of the Securities and Exchange Commission, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate sale price."}],"balance_after":108458,"source":{"system":"sec-edgar","filing":"0001567619-22-001197","document":"doc1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1246406/000156761922001197/doc1.xml","form_type":"4"}},{"id":2434732,"issuer":{"id":2172,"kind":"organization","name":"10x Genomics, Inc.","symbol":"TXG"},"owners":[{"id":124251,"kind":"person","name":"CRUTCHFIELD BRADFORD","position":1,"cik":"0001246406","reported_name":"CRUTCHFIELD BRADFORD","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Commercial Officer"}}],"security":"Class A Common Stock","published_at":"2022-01-14T16:32:12.000Z","date":"2022-01-12","kind":"exercise","acquired":true,"shares":17000,"price":1.16,"value":19720.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The transactions reported herein were effected pursuant to the Reporting Person's Rule 10b5-1 trading plan."}],"balance_after":114653,"source":{"system":"sec-edgar","filing":"0001567619-22-001197","document":"doc1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1246406/000156761922001197/doc1.xml","form_type":"4"}},{"id":2459451,"issuer":{"id":2172,"kind":"organization","name":"10x Genomics, Inc.","symbol":"TXG"},"owners":[{"id":124251,"kind":"person","name":"CRUTCHFIELD BRADFORD","position":1,"cik":"0001246406","reported_name":"CRUTCHFIELD BRADFORD","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Commercial Officer"}}],"security":"Stock Option (right to buy)","published_at":"2021-12-23T16:26:01.000Z","date":"2021-12-21","kind":"exercise","acquired":false,"shares":49910,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"This option, originally for 125,000 shares, of which 63,243 shares have been exercised, vested as to 1/48th of the shares on October 1, 2018, and 1/48th of the shares subject to the option vested each month thereafter, subject to the Reporting Person continuing as a service provider through each such date."}],"balance_after":61757,"derivative":{"exercise_price":5.04,"expiration_date":"2028-11-02","underlying":"Class A Common Stock","underlying_shares":49910},"source":{"system":"sec-edgar","filing":"0001567619-21-022503","document":"doc1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1246406/000156761921022503/doc1.xml","form_type":"4"}},{"id":2459450,"issuer":{"id":2172,"kind":"organization","name":"10x Genomics, Inc.","symbol":"TXG"},"owners":[{"id":124251,"kind":"person","name":"CRUTCHFIELD BRADFORD","position":1,"cik":"0001246406","reported_name":"CRUTCHFIELD BRADFORD","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Commercial Officer"}}],"security":"Stock Option (right to buy)","published_at":"2021-12-23T16:26:01.000Z","date":"2021-12-21","kind":"exercise","acquired":false,"shares":4688,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"This option, originally for 25,000 shares, of which 25,000 shares have been exercised, vested as to 1/48th of the shares on October 1, 2017, and 1/48th of the shares subject to the option vested each month thereafter, subject to the Reporting Person continuing as a service provider through each such date."}],"balance_after":0,"derivative":{"exercise_price":1.2,"expiration_date":"2027-10-18","underlying":"Class A Common Stock","underlying_shares":4688},"source":{"system":"sec-edgar","filing":"0001567619-21-022503","document":"doc1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1246406/000156761921022503/doc1.xml","form_type":"4"}},{"id":2459449,"issuer":{"id":2172,"kind":"organization","name":"10x Genomics, Inc.","symbol":"TXG"},"owners":[{"id":124251,"kind":"person","name":"CRUTCHFIELD BRADFORD","position":1,"cik":"0001246406","reported_name":"CRUTCHFIELD BRADFORD","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Commercial Officer"}}],"security":"Class A Common Stock","published_at":"2021-12-23T16:26:01.000Z","date":"2021-12-21","kind":"exercise","acquired":true,"shares":49910,"price":5.04,"value":251546.4,"ownership":{"direct":true},"balance_after":97653,"source":{"system":"sec-edgar","filing":"0001567619-21-022503","document":"doc1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1246406/000156761921022503/doc1.xml","form_type":"4"}},{"id":2459448,"issuer":{"id":2172,"kind":"organization","name":"10x Genomics, Inc.","symbol":"TXG"},"owners":[{"id":124251,"kind":"person","name":"CRUTCHFIELD BRADFORD","position":1,"cik":"0001246406","reported_name":"CRUTCHFIELD BRADFORD","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Commercial Officer"}}],"security":"Class A Common Stock","published_at":"2021-12-23T16:26:01.000Z","date":"2021-12-21","kind":"exercise","acquired":true,"shares":4688,"price":1.2,"value":5625.6,"ownership":{"direct":true},"balance_after":47743,"source":{"system":"sec-edgar","filing":"0001567619-21-022503","document":"doc1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1246406/000156761921022503/doc1.xml","form_type":"4"}},{"id":2471406,"issuer":{"id":2172,"kind":"organization","name":"10x Genomics, Inc.","symbol":"TXG"},"owners":[{"id":124251,"kind":"person","name":"CRUTCHFIELD BRADFORD","position":1,"cik":"0001246406","reported_name":"CRUTCHFIELD BRADFORD","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Commercial Officer"}}],"security":"Stock Option (right to buy)","published_at":"2021-12-15T19:07:06.000Z","date":"2021-12-13","kind":"exercise","acquired":false,"shares":17000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The transactions reported herein were effected pursuant to the Reporting Person's Rule 10b5-1 trading plan."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F7","text":"This option, originally for 800,000 shares, of which 374,000 shares have been exercised, vested as to one-fourth of the shares on February 2, 2018 and one forty-eighth of the shares subject to the option vest each month thereafter, subject to the Reporting Person continuing as a service provider through each such date."}],"balance_after":426000,"derivative":{"exercise_price":1.16,"expiration_date":"2027-02-03","underlying":"Class A Common Stock","underlying_shares":17000},"source":{"system":"sec-edgar","filing":"0001567619-21-022118","document":"doc1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":8,"url":"https://www.sec.gov/Archives/edgar/data/1246406/000156761921022118/doc1.xml","form_type":"4"}},{"id":2471405,"issuer":{"id":2172,"kind":"organization","name":"10x Genomics, Inc.","symbol":"TXG"},"owners":[{"id":124251,"kind":"person","name":"CRUTCHFIELD BRADFORD","position":1,"cik":"0001246406","reported_name":"CRUTCHFIELD BRADFORD","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Commercial Officer"}}],"security":"Class A Common Stock","published_at":"2021-12-15T19:07:06.000Z","date":"2021-12-13","kind":"sale","acquired":false,"shares":100,"price":142.47,"value":14247.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The transactions reported herein were effected pursuant to the Reporting Person's Rule 10b5-1 trading plan."}],"balance_after":43055,"source":{"system":"sec-edgar","filing":"0001567619-21-022118","document":"doc1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":7,"url":"https://www.sec.gov/Archives/edgar/data/1246406/000156761921022118/doc1.xml","form_type":"4"}},{"id":2471404,"issuer":{"id":2172,"kind":"organization","name":"10x Genomics, Inc.","symbol":"TXG"},"owners":[{"id":124251,"kind":"person","name":"CRUTCHFIELD BRADFORD","position":1,"cik":"0001246406","reported_name":"CRUTCHFIELD BRADFORD","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Commercial Officer"}}],"security":"Class A Common Stock","published_at":"2021-12-15T19:07:06.000Z","date":"2021-12-13","kind":"sale","acquired":false,"shares":800,"price":141.311,"value":113048.8,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The transactions reported herein were effected pursuant to the Reporting Person's Rule 10b5-1 trading plan."},{"field":"price","element":"transactionPricePerShare","label":"F6","text":"This transaction was executed in multiple trades at prices ranging from $141.02 to $141.895. The price reported above reflects the weighted average sale price. The Reporting Person undertakes to provide upon request by the staff of the Securities and Exchange Commission, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate sale price."}],"balance_after":43155,"source":{"system":"sec-edgar","filing":"0001567619-21-022118","document":"doc1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/1246406/000156761921022118/doc1.xml","form_type":"4"}},{"id":2471403,"issuer":{"id":2172,"kind":"organization","name":"10x Genomics, Inc.","symbol":"TXG"},"owners":[{"id":124251,"kind":"person","name":"CRUTCHFIELD BRADFORD","position":1,"cik":"0001246406","reported_name":"CRUTCHFIELD BRADFORD","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Commercial Officer"}}],"security":"Class A Common Stock","published_at":"2021-12-15T19:07:06.000Z","date":"2021-12-13","kind":"sale","acquired":false,"shares":1701,"price":140.3832,"value":238791.8232,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The transactions reported herein were effected pursuant to the Reporting Person's Rule 10b5-1 trading plan."},{"field":"price","element":"transactionPricePerShare","label":"F5","text":"This transaction was executed in multiple trades at prices ranging from $140.01 to $140.90. The price reported above reflects the weighted average sale price. The Reporting Person undertakes to provide upon request by the staff of the Securities and Exchange Commission, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate sale price."}],"balance_after":43955,"source":{"system":"sec-edgar","filing":"0001567619-21-022118","document":"doc1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1246406/000156761921022118/doc1.xml","form_type":"4"}},{"id":2471402,"issuer":{"id":2172,"kind":"organization","name":"10x Genomics, Inc.","symbol":"TXG"},"owners":[{"id":124251,"kind":"person","name":"CRUTCHFIELD BRADFORD","position":1,"cik":"0001246406","reported_name":"CRUTCHFIELD BRADFORD","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Commercial Officer"}}],"security":"Class A Common Stock","published_at":"2021-12-15T19:07:06.000Z","date":"2021-12-13","kind":"sale","acquired":false,"shares":9599,"price":139.5186,"value":1339239.0414,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The transactions reported herein were effected pursuant to the Reporting Person's Rule 10b5-1 trading plan."},{"field":"price","element":"transactionPricePerShare","label":"F4","text":"This transaction was executed in multiple trades at prices ranging from $139.00 to $139.99. The price reported above reflects the weighted average sale price. The Reporting Person undertakes to provide upon request by the staff of the Securities and Exchange Commission, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate sale price."}],"balance_after":45656,"source":{"system":"sec-edgar","filing":"0001567619-21-022118","document":"doc1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1246406/000156761921022118/doc1.xml","form_type":"4"}},{"id":2471401,"issuer":{"id":2172,"kind":"organization","name":"10x Genomics, Inc.","symbol":"TXG"},"owners":[{"id":124251,"kind":"person","name":"CRUTCHFIELD BRADFORD","position":1,"cik":"0001246406","reported_name":"CRUTCHFIELD BRADFORD","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Commercial Officer"}}],"security":"Class A Common Stock","published_at":"2021-12-15T19:07:06.000Z","date":"2021-12-13","kind":"sale","acquired":false,"shares":3235,"price":138.6009,"value":448373.9115,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The transactions reported herein were effected pursuant to the Reporting Person's Rule 10b5-1 trading plan."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"This transaction was executed in multiple trades at prices ranging from $138.00 to $138.99. The price reported above reflects the weighted average sale price. The Reporting Person undertakes to provide upon request by the staff of the Securities and Exchange Commission, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate sale price."}],"balance_after":55255,"source":{"system":"sec-edgar","filing":"0001567619-21-022118","document":"doc1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1246406/000156761921022118/doc1.xml","form_type":"4"}},{"id":2471400,"issuer":{"id":2172,"kind":"organization","name":"10x Genomics, Inc.","symbol":"TXG"},"owners":[{"id":124251,"kind":"person","name":"CRUTCHFIELD BRADFORD","position":1,"cik":"0001246406","reported_name":"CRUTCHFIELD BRADFORD","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Commercial Officer"}}],"security":"Class A Common Stock","published_at":"2021-12-15T19:07:06.000Z","date":"2021-12-13","kind":"sale","acquired":false,"shares":1565,"price":137.6331,"value":215395.8015,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The transactions reported herein were effected pursuant to the Reporting Person's Rule 10b5-1 trading plan."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"This transaction was executed in multiple trades at prices ranging from $137.00 to $137.97. The price reported above reflects the weighted average sale price. The Reporting Person undertakes to provide upon request by the staff of the Securities and Exchange Commission, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate sale price."}],"balance_after":58490,"source":{"system":"sec-edgar","filing":"0001567619-21-022118","document":"doc1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1246406/000156761921022118/doc1.xml","form_type":"4"}},{"id":2471399,"issuer":{"id":2172,"kind":"organization","name":"10x Genomics, Inc.","symbol":"TXG"},"owners":[{"id":124251,"kind":"person","name":"CRUTCHFIELD BRADFORD","position":1,"cik":"0001246406","reported_name":"CRUTCHFIELD BRADFORD","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Commercial Officer"}}],"security":"Class A Common Stock","published_at":"2021-12-15T19:07:06.000Z","date":"2021-12-13","kind":"exercise","acquired":true,"shares":17000,"price":1.16,"value":19720.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The transactions reported herein were effected pursuant to the Reporting Person's Rule 10b5-1 trading plan."}],"balance_after":60055,"source":{"system":"sec-edgar","filing":"0001567619-21-022118","document":"doc1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1246406/000156761921022118/doc1.xml","form_type":"4"}},{"id":2495013,"issuer":{"id":2172,"kind":"organization","name":"10x Genomics, Inc.","symbol":"TXG"},"owners":[{"id":124251,"kind":"person","name":"CRUTCHFIELD BRADFORD","position":1,"cik":"0001246406","reported_name":"CRUTCHFIELD BRADFORD","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Commercial Officer"}}],"security":"Class A Common Stock","published_at":"2021-11-24T21:09:59.000Z","date":"2021-11-22","kind":"sale","acquired":false,"shares":281,"price":148.3811,"value":41695.0891,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The shares were sold to cover tax withholding obligations in connection with the vesting of restricted stock units."}],"balance_after":43055,"source":{"system":"sec-edgar","filing":"0001567619-21-021188","document":"doc1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1246406/000156761921021188/doc1.xml","form_type":"4"}},{"id":2510307,"issuer":{"id":2172,"kind":"organization","name":"10x Genomics, Inc.","symbol":"TXG"},"owners":[{"id":124251,"kind":"person","name":"CRUTCHFIELD BRADFORD","position":1,"cik":"0001246406","reported_name":"CRUTCHFIELD BRADFORD","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Commercial Officer"}}],"security":"Stock Option (right to buy)","published_at":"2021-11-16T18:47:44.000Z","date":"2021-11-12","kind":"exercise","acquired":false,"shares":17000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The transactions reported herein were effected pursuant to the Reporting Person's Rule 10b5-1 trading plan."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F6","text":"This option, originally for 800,000 shares, of which 357,000 shares have been exercised, vested as to one-fourth of the shares on February 2, 2018 and one forty-eighth of the shares subject to the option vest each month thereafter, subject to the Reporting Person continuing as a service provider through each such date."}],"balance_after":443000,"derivative":{"exercise_price":1.16,"expiration_date":"2027-02-03","underlying":"Class A Common Stock","underlying_shares":17000},"source":{"system":"sec-edgar","filing":"0001567619-21-020599","document":"doc1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":8,"url":"https://www.sec.gov/Archives/edgar/data/1246406/000156761921020599/doc1.xml","form_type":"4"}},{"id":2510306,"issuer":{"id":2172,"kind":"organization","name":"10x Genomics, Inc.","symbol":"TXG"},"owners":[{"id":124251,"kind":"person","name":"CRUTCHFIELD BRADFORD","position":1,"cik":"0001246406","reported_name":"CRUTCHFIELD BRADFORD","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Commercial Officer"}}],"security":"Class A Common Stock","published_at":"2021-11-16T18:47:44.000Z","date":"2021-11-12","kind":"sale","acquired":false,"shares":100,"price":168.34,"value":16834.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The transactions reported herein were effected pursuant to the Reporting Person's Rule 10b5-1 trading plan."}],"balance_after":43336,"source":{"system":"sec-edgar","filing":"0001567619-21-020599","document":"doc1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":7,"url":"https://www.sec.gov/Archives/edgar/data/1246406/000156761921020599/doc1.xml","form_type":"4"}},{"id":2510305,"issuer":{"id":2172,"kind":"organization","name":"10x Genomics, Inc.","symbol":"TXG"},"owners":[{"id":124251,"kind":"person","name":"CRUTCHFIELD BRADFORD","position":1,"cik":"0001246406","reported_name":"CRUTCHFIELD BRADFORD","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Commercial Officer"}}],"security":"Class A Common Stock","published_at":"2021-11-16T18:47:44.000Z","date":"2021-11-12","kind":"sale","acquired":false,"shares":100,"price":167.27,"value":16727.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The transactions reported herein were effected pursuant to the Reporting Person's Rule 10b5-1 trading plan."}],"balance_after":43436,"source":{"system":"sec-edgar","filing":"0001567619-21-020599","document":"doc1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/1246406/000156761921020599/doc1.xml","form_type":"4"}},{"id":2510304,"issuer":{"id":2172,"kind":"organization","name":"10x Genomics, Inc.","symbol":"TXG"},"owners":[{"id":124251,"kind":"person","name":"CRUTCHFIELD BRADFORD","position":1,"cik":"0001246406","reported_name":"CRUTCHFIELD BRADFORD","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Commercial Officer"}}],"security":"Class A Common Stock","published_at":"2021-11-16T18:47:44.000Z","date":"2021-11-12","kind":"sale","acquired":false,"shares":4776,"price":165.8932,"value":792305.9232,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The transactions reported herein were effected pursuant to the Reporting Person's Rule 10b5-1 trading plan."},{"field":"price","element":"transactionPricePerShare","label":"F5","text":"This transaction was executed in multiple trades at prices ranging from $165.51 to $166.44. The price reported above reflects the weighted average sale price. The Reporting Person undertakes to provide upon request by the staff of the Securities and Exchange Commission, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate sale price."}],"balance_after":43536,"source":{"system":"sec-edgar","filing":"0001567619-21-020599","document":"doc1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1246406/000156761921020599/doc1.xml","form_type":"4"}},{"id":2510303,"issuer":{"id":2172,"kind":"organization","name":"10x Genomics, Inc.","symbol":"TXG"},"owners":[{"id":124251,"kind":"person","name":"CRUTCHFIELD BRADFORD","position":1,"cik":"0001246406","reported_name":"CRUTCHFIELD BRADFORD","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Commercial Officer"}}],"security":"Class A Common Stock","published_at":"2021-11-16T18:47:44.000Z","date":"2021-11-12","kind":"sale","acquired":false,"shares":6872,"price":164.8665,"value":1132962.588,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The transactions reported herein were effected pursuant to the Reporting Person's Rule 10b5-1 trading plan."},{"field":"price","element":"transactionPricePerShare","label":"F4","text":"This transaction was executed in multiple trades at prices ranging from $164.50 to $165.49. The price reported above reflects the weighted average sale price. The Reporting Person undertakes to provide upon request by the staff of the Securities and Exchange Commission, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate sale price."}],"balance_after":48312,"source":{"system":"sec-edgar","filing":"0001567619-21-020599","document":"doc1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1246406/000156761921020599/doc1.xml","form_type":"4"}},{"id":2510302,"issuer":{"id":2172,"kind":"organization","name":"10x Genomics, Inc.","symbol":"TXG"},"owners":[{"id":124251,"kind":"person","name":"CRUTCHFIELD BRADFORD","position":1,"cik":"0001246406","reported_name":"CRUTCHFIELD BRADFORD","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Commercial Officer"}}],"security":"Class A Common Stock","published_at":"2021-11-16T18:47:44.000Z","date":"2021-11-12","kind":"sale","acquired":false,"shares":4122,"price":164.176,"value":676733.472,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The transactions reported herein were effected pursuant to the Reporting Person's Rule 10b5-1 trading plan."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"This transaction was executed in multiple trades at prices ranging from $163.50 to $164.495. The price reported above reflects the weighted average sale price. The Reporting Person undertakes to provide upon request by the staff of the Securities and Exchange Commission, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate sale price."}],"balance_after":55184,"source":{"system":"sec-edgar","filing":"0001567619-21-020599","document":"doc1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1246406/000156761921020599/doc1.xml","form_type":"4"}},{"id":2510301,"issuer":{"id":2172,"kind":"organization","name":"10x Genomics, Inc.","symbol":"TXG"},"owners":[{"id":124251,"kind":"person","name":"CRUTCHFIELD BRADFORD","position":1,"cik":"0001246406","reported_name":"CRUTCHFIELD BRADFORD","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Commercial Officer"}}],"security":"Class A Common Stock","published_at":"2021-11-16T18:47:44.000Z","date":"2021-11-12","kind":"sale","acquired":false,"shares":1030,"price":163.1013,"value":167994.339,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The transactions reported herein were effected pursuant to the Reporting Person's Rule 10b5-1 trading plan."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"This transaction was executed in multiple trades at prices ranging from $162.49 to $163.47. The price reported above reflects the weighted average sale price. The Reporting Person undertakes to provide upon request by the staff of the Securities and Exchange Commission, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate sale price."}],"balance_after":59306,"source":{"system":"sec-edgar","filing":"0001567619-21-020599","document":"doc1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1246406/000156761921020599/doc1.xml","form_type":"4"}},{"id":2510300,"issuer":{"id":2172,"kind":"organization","name":"10x Genomics, Inc.","symbol":"TXG"},"owners":[{"id":124251,"kind":"person","name":"CRUTCHFIELD BRADFORD","position":1,"cik":"0001246406","reported_name":"CRUTCHFIELD BRADFORD","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Commercial Officer"}}],"security":"Class A Common Stock","published_at":"2021-11-16T18:47:44.000Z","date":"2021-11-12","kind":"exercise","acquired":true,"shares":17000,"price":1.16,"value":19720.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The transactions reported herein were effected pursuant to the Reporting Person's Rule 10b5-1 trading plan."}],"balance_after":60336,"source":{"system":"sec-edgar","filing":"0001567619-21-020599","document":"doc1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1246406/000156761921020599/doc1.xml","form_type":"4"}},{"id":2542287,"issuer":{"id":2172,"kind":"organization","name":"10x Genomics, Inc.","symbol":"TXG"},"owners":[{"id":124251,"kind":"person","name":"CRUTCHFIELD BRADFORD","position":1,"cik":"0001246406","reported_name":"CRUTCHFIELD BRADFORD","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Commercial Officer"}}],"security":"Stock Option (right to buy)","published_at":"2021-10-14T18:16:06.000Z","date":"2021-10-12","kind":"exercise","acquired":false,"shares":17000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The transactions reported herein were effected pursuant to the Reporting Person's Rule 10b5-1 trading plan."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F5","text":"This option, originally for 800,000 shares, of which 340,000 shares have been exercised, vested as to one-fourth of the shares on February 2, 2018 and one forty-eighth of the shares subject to the option vest each month thereafter, subject to the Reporting Person continuing as a service provider through each such date."}],"balance_after":460000,"derivative":{"exercise_price":1.16,"expiration_date":"2027-02-03","underlying":"Class A Common Stock","underlying_shares":17000},"source":{"system":"sec-edgar","filing":"0001567619-21-018312","document":"doc1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1246406/000156761921018312/doc1.xml","form_type":"4"}},{"id":2542286,"issuer":{"id":2172,"kind":"organization","name":"10x Genomics, Inc.","symbol":"TXG"},"owners":[{"id":124251,"kind":"person","name":"CRUTCHFIELD BRADFORD","position":1,"cik":"0001246406","reported_name":"CRUTCHFIELD BRADFORD","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Commercial Officer"}}],"security":"Class A Common Stock","published_at":"2021-10-14T18:16:06.000Z","date":"2021-10-12","kind":"sale","acquired":false,"shares":3043,"price":158.6315,"value":482715.6545,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The transactions reported herein were effected pursuant to the Reporting Person's Rule 10b5-1 trading plan."},{"field":"price","element":"transactionPricePerShare","label":"F4","text":"This transaction was executed in multiple trades at prices ranging from $158.09 to $159.02. The price reported above reflects the weighted average sale price. The Reporting Person undertakes to provide upon request by the staff of the Securities and Exchange Commission, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate sale price."}],"balance_after":43336,"source":{"system":"sec-edgar","filing":"0001567619-21-018312","document":"doc1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1246406/000156761921018312/doc1.xml","form_type":"4"}},{"id":2542285,"issuer":{"id":2172,"kind":"organization","name":"10x Genomics, Inc.","symbol":"TXG"},"owners":[{"id":124251,"kind":"person","name":"CRUTCHFIELD BRADFORD","position":1,"cik":"0001246406","reported_name":"CRUTCHFIELD BRADFORD","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Commercial Officer"}}],"security":"Class A Common Stock","published_at":"2021-10-14T18:16:06.000Z","date":"2021-10-12","kind":"sale","acquired":false,"shares":7997,"price":157.404,"value":1258759.788,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The transactions reported herein were effected pursuant to the Reporting Person's Rule 10b5-1 trading plan."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"This transaction was executed in multiple trades at prices ranging from $156.95 to $157.94. The price reported above reflects the weighted average sale price. The Reporting Person undertakes to provide upon request by the staff of the Securities and Exchange Commission, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate sale price."}],"balance_after":46379,"source":{"system":"sec-edgar","filing":"0001567619-21-018312","document":"doc1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1246406/000156761921018312/doc1.xml","form_type":"4"}},{"id":2542284,"issuer":{"id":2172,"kind":"organization","name":"10x Genomics, Inc.","symbol":"TXG"},"owners":[{"id":124251,"kind":"person","name":"CRUTCHFIELD BRADFORD","position":1,"cik":"0001246406","reported_name":"CRUTCHFIELD BRADFORD","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Commercial Officer"}}],"security":"Class A Common Stock","published_at":"2021-10-14T18:16:06.000Z","date":"2021-10-12","kind":"sale","acquired":false,"shares":5960,"price":156.4896,"value":932678.016,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The transactions reported herein were effected pursuant to the Reporting Person's Rule 10b5-1 trading plan."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"This transaction was executed in multiple trades at prices ranging from $155.95 to $156.94. The price reported above reflects the weighted average sale price. The Reporting Person undertakes to provide upon request by the staff of the Securities and Exchange Commission, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate sale price."}],"balance_after":54376,"source":{"system":"sec-edgar","filing":"0001567619-21-018312","document":"doc1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1246406/000156761921018312/doc1.xml","form_type":"4"}},{"id":2542283,"issuer":{"id":2172,"kind":"organization","name":"10x Genomics, Inc.","symbol":"TXG"},"owners":[{"id":124251,"kind":"person","name":"CRUTCHFIELD BRADFORD","position":1,"cik":"0001246406","reported_name":"CRUTCHFIELD BRADFORD","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Commercial Officer"}}],"security":"Class A Common Stock","published_at":"2021-10-14T18:16:06.000Z","date":"2021-10-12","kind":"exercise","acquired":true,"shares":17000,"price":1.16,"value":19720.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The transactions reported herein were effected pursuant to the Reporting Person's Rule 10b5-1 trading plan."}],"balance_after":60336,"source":{"system":"sec-edgar","filing":"0001567619-21-018312","document":"doc1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1246406/000156761921018312/doc1.xml","form_type":"4"}},{"id":2569119,"issuer":{"id":2172,"kind":"organization","name":"10x Genomics, Inc.","symbol":"TXG"},"owners":[{"id":124251,"kind":"person","name":"CRUTCHFIELD BRADFORD","position":1,"cik":"0001246406","reported_name":"CRUTCHFIELD BRADFORD","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Commercial Officer"}}],"security":"Stock Option (right to buy)","published_at":"2021-09-15T18:09:16.000Z","date":"2021-09-13","kind":"exercise","acquired":false,"shares":17000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The option exercise and sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan entered into by the Reporting Person."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F12","text":"This option, originally for 800,000 shares, of which 323,000 shares have been exercised, vested as to one-fourth of the shares on February 2, 2018 and one forty-eighth of the shares subject to the option vest each month thereafter, subject to the Reporting Person continuing as a service provider through each such date."}],"balance_after":477000,"derivative":{"exercise_price":1.16,"expiration_date":"2027-02-03","underlying":"Class A Common Stock","underlying_shares":17000},"source":{"system":"sec-edgar","filing":"0001209191-21-056229","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":14,"url":"https://www.sec.gov/Archives/edgar/data/1246406/000120919121056229/doc4.xml","form_type":"4"}},{"id":2569118,"issuer":{"id":2172,"kind":"organization","name":"10x Genomics, Inc.","symbol":"TXG"},"owners":[{"id":124251,"kind":"person","name":"CRUTCHFIELD BRADFORD","position":1,"cik":"0001246406","reported_name":"CRUTCHFIELD BRADFORD","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Commercial Officer"}}],"security":"Class A Common Stock","published_at":"2021-09-15T18:09:16.000Z","date":"2021-09-13","kind":"sale","acquired":false,"shares":100,"price":184.32,"value":18432.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The option exercise and sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan entered into by the Reporting Person."}],"balance_after":43336,"source":{"system":"sec-edgar","filing":"0001209191-21-056229","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":13,"url":"https://www.sec.gov/Archives/edgar/data/1246406/000120919121056229/doc4.xml","form_type":"4"}},{"id":2569117,"issuer":{"id":2172,"kind":"organization","name":"10x Genomics, Inc.","symbol":"TXG"},"owners":[{"id":124251,"kind":"person","name":"CRUTCHFIELD BRADFORD","position":1,"cik":"0001246406","reported_name":"CRUTCHFIELD BRADFORD","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Commercial Officer"}}],"security":"Class A Common Stock","published_at":"2021-09-15T18:09:16.000Z","date":"2021-09-13","kind":"sale","acquired":false,"shares":100,"price":181.235,"value":18123.5,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The option exercise and sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan entered into by the Reporting Person."}],"balance_after":43436,"source":{"system":"sec-edgar","filing":"0001209191-21-056229","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":12,"url":"https://www.sec.gov/Archives/edgar/data/1246406/000120919121056229/doc4.xml","form_type":"4"}},{"id":2569116,"issuer":{"id":2172,"kind":"organization","name":"10x Genomics, Inc.","symbol":"TXG"},"owners":[{"id":124251,"kind":"person","name":"CRUTCHFIELD BRADFORD","position":1,"cik":"0001246406","reported_name":"CRUTCHFIELD BRADFORD","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Commercial Officer"}}],"security":"Class A Common Stock","published_at":"2021-09-15T18:09:16.000Z","date":"2021-09-13","kind":"sale","acquired":false,"shares":500,"price":178.902,"value":89451.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The option exercise and sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan entered into by the Reporting Person."},{"field":"price","element":"transactionPricePerShare","label":"F11","text":"This transaction was executed in multiple trades at prices ranging from $178.81 to $179.02. The price reported above reflects the weighted average sale price. The Reporting Person undertakes to provide upon request by the staff of the Securities and Exchange Commission, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate sale price."}],"balance_after":43536,"source":{"system":"sec-edgar","filing":"0001209191-21-056229","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":11,"url":"https://www.sec.gov/Archives/edgar/data/1246406/000120919121056229/doc4.xml","form_type":"4"}},{"id":2569115,"issuer":{"id":2172,"kind":"organization","name":"10x Genomics, Inc.","symbol":"TXG"},"owners":[{"id":124251,"kind":"person","name":"CRUTCHFIELD BRADFORD","position":1,"cik":"0001246406","reported_name":"CRUTCHFIELD BRADFORD","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Commercial Officer"}}],"security":"Class A Common Stock","published_at":"2021-09-15T18:09:16.000Z","date":"2021-09-13","kind":"sale","acquired":false,"shares":1000,"price":178.237,"value":178237.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The option exercise and sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan entered into by the Reporting Person."},{"field":"price","element":"transactionPricePerShare","label":"F10","text":"This transaction was executed in multiple trades at prices ranging from $177.79 to $178.785. The price reported above reflects the weighted average sale price. The Reporting Person undertakes to provide upon request by the staff of the Securities and Exchange Commission, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate sale price."}],"balance_after":44036,"source":{"system":"sec-edgar","filing":"0001209191-21-056229","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":10,"url":"https://www.sec.gov/Archives/edgar/data/1246406/000120919121056229/doc4.xml","form_type":"4"}},{"id":2569114,"issuer":{"id":2172,"kind":"organization","name":"10x Genomics, Inc.","symbol":"TXG"},"owners":[{"id":124251,"kind":"person","name":"CRUTCHFIELD BRADFORD","position":1,"cik":"0001246406","reported_name":"CRUTCHFIELD BRADFORD","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Commercial Officer"}}],"security":"Class A Common Stock","published_at":"2021-09-15T18:09:16.000Z","date":"2021-09-13","kind":"sale","acquired":false,"shares":1700,"price":177.2109,"value":301258.53,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The option exercise and sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan entered into by the Reporting Person."},{"field":"price","element":"transactionPricePerShare","label":"F9","text":"This transaction was executed in multiple trades at prices ranging from $176.75 to $177.74. The price reported above reflects the weighted average sale price. The Reporting Person undertakes to provide upon request by the staff of the Securities and Exchange Commission, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate sale price."}],"balance_after":45036,"source":{"system":"sec-edgar","filing":"0001209191-21-056229","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":9,"url":"https://www.sec.gov/Archives/edgar/data/1246406/000120919121056229/doc4.xml","form_type":"4"}},{"id":2569113,"issuer":{"id":2172,"kind":"organization","name":"10x Genomics, Inc.","symbol":"TXG"},"owners":[{"id":124251,"kind":"person","name":"CRUTCHFIELD BRADFORD","position":1,"cik":"0001246406","reported_name":"CRUTCHFIELD BRADFORD","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Commercial Officer"}}],"security":"Class A Common Stock","published_at":"2021-09-15T18:09:16.000Z","date":"2021-09-13","kind":"sale","acquired":false,"shares":3906,"price":176.1899,"value":688197.7494,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The option exercise and sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan entered into by the Reporting Person."},{"field":"price","element":"transactionPricePerShare","label":"F8","text":"This transaction was executed in multiple trades at prices ranging from $175.75 to $176.72. The price reported above reflects the weighted average sale price. The Reporting Person undertakes to provide upon request by the staff of the Securities and Exchange Commission, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate sale price."}],"balance_after":46736,"source":{"system":"sec-edgar","filing":"0001209191-21-056229","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":8,"url":"https://www.sec.gov/Archives/edgar/data/1246406/000120919121056229/doc4.xml","form_type":"4"}},{"id":2569112,"issuer":{"id":2172,"kind":"organization","name":"10x Genomics, Inc.","symbol":"TXG"},"owners":[{"id":124251,"kind":"person","name":"CRUTCHFIELD BRADFORD","position":1,"cik":"0001246406","reported_name":"CRUTCHFIELD BRADFORD","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Commercial Officer"}}],"security":"Class A Common Stock","published_at":"2021-09-15T18:09:16.000Z","date":"2021-09-13","kind":"sale","acquired":false,"shares":2694,"price":175.1669,"value":471899.6286,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The option exercise and sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan entered into by the Reporting Person."},{"field":"price","element":"transactionPricePerShare","label":"F7","text":"This transaction was executed in multiple trades at prices ranging from $174.73 to $175.72. The price reported above reflects the weighted average sale price. The Reporting Person undertakes to provide upon request by the staff of the Securities and Exchange Commission, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate sale price."}],"balance_after":50642,"source":{"system":"sec-edgar","filing":"0001209191-21-056229","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":7,"url":"https://www.sec.gov/Archives/edgar/data/1246406/000120919121056229/doc4.xml","form_type":"4"}},{"id":2569111,"issuer":{"id":2172,"kind":"organization","name":"10x Genomics, Inc.","symbol":"TXG"},"owners":[{"id":124251,"kind":"person","name":"CRUTCHFIELD BRADFORD","position":1,"cik":"0001246406","reported_name":"CRUTCHFIELD BRADFORD","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Commercial Officer"}}],"security":"Class A Common Stock","published_at":"2021-09-15T18:09:16.000Z","date":"2021-09-13","kind":"sale","acquired":false,"shares":2700,"price":174.1354,"value":470165.58,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The option exercise and sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan entered into by the Reporting Person."},{"field":"price","element":"transactionPricePerShare","label":"F6","text":"This transaction was executed in multiple trades at prices ranging from $173.67 to $174.65. The price reported above reflects the weighted average sale price. The Reporting Person undertakes to provide upon request by the staff of the Securities and Exchange Commission, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate sale price."}],"balance_after":53336,"source":{"system":"sec-edgar","filing":"0001209191-21-056229","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/1246406/000120919121056229/doc4.xml","form_type":"4"}},{"id":2569110,"issuer":{"id":2172,"kind":"organization","name":"10x Genomics, Inc.","symbol":"TXG"},"owners":[{"id":124251,"kind":"person","name":"CRUTCHFIELD BRADFORD","position":1,"cik":"0001246406","reported_name":"CRUTCHFIELD BRADFORD","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Commercial Officer"}}],"security":"Class A Common Stock","published_at":"2021-09-15T18:09:16.000Z","date":"2021-09-13","kind":"sale","acquired":false,"shares":400,"price":172.395,"value":68958.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The option exercise and sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan entered into by the Reporting Person."},{"field":"price","element":"transactionPricePerShare","label":"F5","text":"This transaction was executed in multiple trades at prices ranging from $172.30 to $172.48. The price reported above reflects the weighted average sale price. The Reporting Person undertakes to provide upon request by the staff of the Securities and Exchange Commission, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate sale price."}],"balance_after":56036,"source":{"system":"sec-edgar","filing":"0001209191-21-056229","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1246406/000120919121056229/doc4.xml","form_type":"4"}},{"id":2569109,"issuer":{"id":2172,"kind":"organization","name":"10x Genomics, Inc.","symbol":"TXG"},"owners":[{"id":124251,"kind":"person","name":"CRUTCHFIELD BRADFORD","position":1,"cik":"0001246406","reported_name":"CRUTCHFIELD BRADFORD","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Commercial Officer"}}],"security":"Class A Common Stock","published_at":"2021-09-15T18:09:16.000Z","date":"2021-09-13","kind":"sale","acquired":false,"shares":300,"price":171.2033,"value":51360.99,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The option exercise and sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan entered into by the Reporting Person."},{"field":"price","element":"transactionPricePerShare","label":"F4","text":"This transaction was executed in multiple trades at prices ranging from $170.88 to $171.66. The price reported above reflects the weighted average sale price. The Reporting Person undertakes to provide upon request by the staff of the Securities and Exchange Commission, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate sale price."}],"balance_after":56436,"source":{"system":"sec-edgar","filing":"0001209191-21-056229","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1246406/000120919121056229/doc4.xml","form_type":"4"}},{"id":2569108,"issuer":{"id":2172,"kind":"organization","name":"10x Genomics, Inc.","symbol":"TXG"},"owners":[{"id":124251,"kind":"person","name":"CRUTCHFIELD BRADFORD","position":1,"cik":"0001246406","reported_name":"CRUTCHFIELD BRADFORD","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Commercial Officer"}}],"security":"Class A Common Stock","published_at":"2021-09-15T18:09:16.000Z","date":"2021-09-13","kind":"sale","acquired":false,"shares":1300,"price":170.3034,"value":221394.42,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The option exercise and sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan entered into by the Reporting Person."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"This transaction was executed in multiple trades at prices ranging from $169.865 to $170.79. The price reported above reflects the weighted average sale price. The Reporting Person undertakes to provide upon request by the staff of the Securities and Exchange Commission, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate sale price."}],"balance_after":56736,"source":{"system":"sec-edgar","filing":"0001209191-21-056229","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1246406/000120919121056229/doc4.xml","form_type":"4"}},{"id":2569107,"issuer":{"id":2172,"kind":"organization","name":"10x Genomics, Inc.","symbol":"TXG"},"owners":[{"id":124251,"kind":"person","name":"CRUTCHFIELD BRADFORD","position":1,"cik":"0001246406","reported_name":"CRUTCHFIELD BRADFORD","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Commercial Officer"}}],"security":"Class A Common Stock","published_at":"2021-09-15T18:09:16.000Z","date":"2021-09-13","kind":"sale","acquired":false,"shares":2300,"price":169.0582,"value":388833.86,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The option exercise and sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan entered into by the Reporting Person."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"This transaction was executed in multiple trades at prices ranging from $168.75 to $169.70. The price reported above reflects the weighted average sale price. The Reporting Person undertakes to provide upon request by the staff of the Securities and Exchange Commission, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate sale price."}],"balance_after":58036,"source":{"system":"sec-edgar","filing":"0001209191-21-056229","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1246406/000120919121056229/doc4.xml","form_type":"4"}},{"id":2569106,"issuer":{"id":2172,"kind":"organization","name":"10x Genomics, Inc.","symbol":"TXG"},"owners":[{"id":124251,"kind":"person","name":"CRUTCHFIELD BRADFORD","position":1,"cik":"0001246406","reported_name":"CRUTCHFIELD BRADFORD","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Commercial Officer"}}],"security":"Class A Common Stock","published_at":"2021-09-15T18:09:16.000Z","date":"2021-09-13","kind":"exercise","acquired":true,"shares":17000,"price":1.16,"value":19720.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The option exercise and sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan entered into by the Reporting Person."}],"balance_after":60336,"source":{"system":"sec-edgar","filing":"0001209191-21-056229","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1246406/000120919121056229/doc4.xml","form_type":"4"}},{"id":2590708,"issuer":{"id":2172,"kind":"organization","name":"10x Genomics, Inc.","symbol":"TXG"},"owners":[{"id":124251,"kind":"person","name":"CRUTCHFIELD BRADFORD","position":1,"cik":"0001246406","reported_name":"CRUTCHFIELD BRADFORD","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Commercial Officer"}}],"security":"Class A Common Stock","published_at":"2021-08-25T20:36:10.000Z","date":"2021-08-23","kind":"sale","acquired":false,"shares":270,"price":161.8475,"value":43698.825,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"These shares were sold to cover tax withholding obligations in connection with the vesting of restricted stock units."}],"balance_after":43336,"source":{"system":"sec-edgar","filing":"0001209191-21-053390","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1246406/000120919121053390/doc4.xml","form_type":"4"}},{"id":2602067,"issuer":{"id":2172,"kind":"organization","name":"10x Genomics, Inc.","symbol":"TXG"},"owners":[{"id":124251,"kind":"person","name":"CRUTCHFIELD BRADFORD","position":1,"cik":"0001246406","reported_name":"CRUTCHFIELD BRADFORD","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Commercial Officer"}}],"security":"Stock Option (right to buy)","published_at":"2021-08-16T16:06:12.000Z","date":"2021-08-12","kind":"exercise","acquired":false,"shares":17000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The option exercise and sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan entered into by the Reporting Person."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F8","text":"This option, originally for 800,000 shares, of which 306,000 shares have been exercised, vested as to one-fourth of the shares on February 2, 2018 and one forty-eighth of the shares subject to the option vest each month thereafter, subject to the Reporting Person continuing as a service provider through each such date."}],"balance_after":494000,"derivative":{"exercise_price":1.16,"expiration_date":"2027-02-03","underlying":"Class A Common Stock","underlying_shares":17000},"source":{"system":"sec-edgar","filing":"0001209191-21-051618","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":8,"url":"https://www.sec.gov/Archives/edgar/data/1246406/000120919121051618/doc4.xml","form_type":"4"}},{"id":2602066,"issuer":{"id":2172,"kind":"organization","name":"10x Genomics, Inc.","symbol":"TXG"},"owners":[{"id":124251,"kind":"person","name":"CRUTCHFIELD BRADFORD","position":1,"cik":"0001246406","reported_name":"CRUTCHFIELD BRADFORD","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Commercial Officer"}}],"security":"Class A Common Stock","published_at":"2021-08-16T16:06:12.000Z","date":"2021-08-12","kind":"sale","acquired":false,"shares":800,"price":161.84,"value":129472.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The option exercise and sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan entered into by the Reporting Person."},{"field":"price","element":"transactionPricePerShare","label":"F7","text":"This transaction was executed in multiple trades at prices ranging from $161.62 to $162.01. The price reported above reflects the weighted average sale price. The Reporting Person undertakes to provide upon request by the staff of the Securities and Exchange Commission, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate sale price."}],"balance_after":43606,"source":{"system":"sec-edgar","filing":"0001209191-21-051618","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":7,"url":"https://www.sec.gov/Archives/edgar/data/1246406/000120919121051618/doc4.xml","form_type":"4"}},{"id":2602065,"issuer":{"id":2172,"kind":"organization","name":"10x Genomics, Inc.","symbol":"TXG"},"owners":[{"id":124251,"kind":"person","name":"CRUTCHFIELD BRADFORD","position":1,"cik":"0001246406","reported_name":"CRUTCHFIELD BRADFORD","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Commercial Officer"}}],"security":"Class A Common Stock","published_at":"2021-08-16T16:06:12.000Z","date":"2021-08-12","kind":"sale","acquired":false,"shares":5087,"price":161.2809,"value":820435.9383,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The option exercise and sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan entered into by the Reporting Person."},{"field":"price","element":"transactionPricePerShare","label":"F6","text":"This transaction was executed in multiple trades at prices ranging from $160.62 to $161.61. The price reported above reflects the weighted average sale price. The Reporting Person undertakes to provide upon request by the staff of the Securities and Exchange Commission, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate sale price."}],"balance_after":44406,"source":{"system":"sec-edgar","filing":"0001209191-21-051618","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/1246406/000120919121051618/doc4.xml","form_type":"4"}},{"id":2602064,"issuer":{"id":2172,"kind":"organization","name":"10x Genomics, Inc.","symbol":"TXG"},"owners":[{"id":124251,"kind":"person","name":"CRUTCHFIELD BRADFORD","position":1,"cik":"0001246406","reported_name":"CRUTCHFIELD BRADFORD","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Commercial Officer"}}],"security":"Class A Common Stock","published_at":"2021-08-16T16:06:12.000Z","date":"2021-08-12","kind":"sale","acquired":false,"shares":3400,"price":160.0032,"value":544010.88,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The option exercise and sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan entered into by the Reporting Person."},{"field":"price","element":"transactionPricePerShare","label":"F5","text":"This transaction was executed in multiple trades at prices ranging from $159.64 to $160.56. The price reported above reflects the weighted average sale price. The Reporting Person undertakes to provide upon request by the staff of the Securities and Exchange Commission, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate sale price."}],"balance_after":49493,"source":{"system":"sec-edgar","filing":"0001209191-21-051618","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1246406/000120919121051618/doc4.xml","form_type":"4"}},{"id":2602063,"issuer":{"id":2172,"kind":"organization","name":"10x Genomics, Inc.","symbol":"TXG"},"owners":[{"id":124251,"kind":"person","name":"CRUTCHFIELD BRADFORD","position":1,"cik":"0001246406","reported_name":"CRUTCHFIELD BRADFORD","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Commercial Officer"}}],"security":"Class A Common Stock","published_at":"2021-08-16T16:06:12.000Z","date":"2021-08-12","kind":"sale","acquired":false,"shares":3213,"price":159.1315,"value":511289.5095,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The option exercise and sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan entered into by the Reporting Person."},{"field":"price","element":"transactionPricePerShare","label":"F4","text":"This transaction was executed in multiple trades at prices ranging from $158.66 to $159.61. The price reported above reflects the weighted average sale price. The Reporting Person undertakes to provide upon request by the staff of the Securities and Exchange Commission, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate sale price."}],"balance_after":52893,"source":{"system":"sec-edgar","filing":"0001209191-21-051618","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1246406/000120919121051618/doc4.xml","form_type":"4"}},{"id":2602062,"issuer":{"id":2172,"kind":"organization","name":"10x Genomics, Inc.","symbol":"TXG"},"owners":[{"id":124251,"kind":"person","name":"CRUTCHFIELD BRADFORD","position":1,"cik":"0001246406","reported_name":"CRUTCHFIELD BRADFORD","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Commercial Officer"}}],"security":"Class A Common Stock","published_at":"2021-08-16T16:06:12.000Z","date":"2021-08-12","kind":"sale","acquired":false,"shares":2400,"price":158.0723,"value":379373.52,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The option exercise and sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan entered into by the Reporting Person."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"This transaction was executed in multiple trades at prices ranging from $157.66 to $158.63. The price reported above reflects the weighted average sale price. The Reporting Person undertakes to provide upon request by the staff of the Securities and Exchange Commission, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate sale price."}],"balance_after":56106,"source":{"system":"sec-edgar","filing":"0001209191-21-051618","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1246406/000120919121051618/doc4.xml","form_type":"4"}},{"id":2602061,"issuer":{"id":2172,"kind":"organization","name":"10x Genomics, Inc.","symbol":"TXG"},"owners":[{"id":124251,"kind":"person","name":"CRUTCHFIELD BRADFORD","position":1,"cik":"0001246406","reported_name":"CRUTCHFIELD BRADFORD","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Commercial Officer"}}],"security":"Class A Common Stock","published_at":"2021-08-16T16:06:12.000Z","date":"2021-08-12","kind":"sale","acquired":false,"shares":2100,"price":157.1903,"value":330099.63,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The option exercise and sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan entered into by the Reporting Person."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"This transaction was executed in multiple trades at prices ranging from $156.61 to $157.50. The price reported above reflects the weighted average sale price. The Reporting Person undertakes to provide upon request by the staff of the Securities and Exchange Commission, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate sale price."}],"balance_after":58506,"source":{"system":"sec-edgar","filing":"0001209191-21-051618","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1246406/000120919121051618/doc4.xml","form_type":"4"}},{"id":2602060,"issuer":{"id":2172,"kind":"organization","name":"10x Genomics, Inc.","symbol":"TXG"},"owners":[{"id":124251,"kind":"person","name":"CRUTCHFIELD BRADFORD","position":1,"cik":"0001246406","reported_name":"CRUTCHFIELD BRADFORD","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Commercial Officer"}}],"security":"Class A Common Stock","published_at":"2021-08-16T16:06:12.000Z","date":"2021-08-12","kind":"exercise","acquired":true,"shares":17000,"price":1.16,"value":19720.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The option exercise and sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan entered into by the Reporting Person."}],"balance_after":60606,"source":{"system":"sec-edgar","filing":"0001209191-21-051618","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1246406/000120919121051618/doc4.xml","form_type":"4"}},{"id":2633961,"issuer":{"id":2172,"kind":"organization","name":"10x Genomics, Inc.","symbol":"TXG"},"owners":[{"id":124251,"kind":"person","name":"CRUTCHFIELD BRADFORD","position":1,"cik":"0001246406","reported_name":"CRUTCHFIELD BRADFORD","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Commercial Officer"}}],"security":"Stock Option (right to buy)","published_at":"2021-07-14T16:42:29.000Z","date":"2021-07-12","kind":"exercise","acquired":false,"shares":17000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The option exercise and sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan entered into by the Reporting Person."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F10","text":"This option, originally for 800,000 shares, of which 289,000 shares have been exercised, vested as to one-fourth of the shares on February 2, 2018 and one forty-eighth of the shares subject to the option vest each month thereafter, subject to the Reporting Person continuing as a service provider through each such date."}],"balance_after":511000,"derivative":{"exercise_price":1.16,"expiration_date":"2027-02-03","underlying":"Class A Common Stock","underlying_shares":17000},"source":{"system":"sec-edgar","filing":"0001209191-21-046677","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":9,"url":"https://www.sec.gov/Archives/edgar/data/1246406/000120919121046677/doc4.xml","form_type":"4"}},{"id":2633960,"issuer":{"id":2172,"kind":"organization","name":"10x Genomics, Inc.","symbol":"TXG"},"owners":[{"id":124251,"kind":"person","name":"CRUTCHFIELD BRADFORD","position":1,"cik":"0001246406","reported_name":"CRUTCHFIELD BRADFORD","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Commercial Officer"}}],"security":"Class A Common Stock","published_at":"2021-07-14T16:42:29.000Z","date":"2021-07-12","kind":"sale","acquired":false,"shares":300,"price":191.6017,"value":57480.51,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The option exercise and sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan entered into by the Reporting Person."},{"field":"price","element":"transactionPricePerShare","label":"F9","text":"This transaction was executed in multiple trades at prices ranging from $191.445 to $191.91. The price reported above reflects the weighted average sale price. The Reporting Person undertakes to provide upon request by the staff of the Securities and Exchange Commission, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate sale price."}],"balance_after":43606,"source":{"system":"sec-edgar","filing":"0001209191-21-046677","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":8,"url":"https://www.sec.gov/Archives/edgar/data/1246406/000120919121046677/doc4.xml","form_type":"4"}},{"id":2633959,"issuer":{"id":2172,"kind":"organization","name":"10x Genomics, Inc.","symbol":"TXG"},"owners":[{"id":124251,"kind":"person","name":"CRUTCHFIELD BRADFORD","position":1,"cik":"0001246406","reported_name":"CRUTCHFIELD BRADFORD","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Commercial Officer"}}],"security":"Class A Common Stock","published_at":"2021-07-14T16:42:29.000Z","date":"2021-07-12","kind":"sale","acquired":false,"shares":600,"price":190.8628,"value":114517.68,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The option exercise and sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan entered into by the Reporting Person."},{"field":"price","element":"transactionPricePerShare","label":"F8","text":"This transaction was executed in multiple trades at prices ranging from $190.41 to $191.16. The price reported above reflects the weighted average sale price. The Reporting Person undertakes to provide upon request by the staff of the Securities and Exchange Commission, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate sale price."}],"balance_after":43906,"source":{"system":"sec-edgar","filing":"0001209191-21-046677","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":7,"url":"https://www.sec.gov/Archives/edgar/data/1246406/000120919121046677/doc4.xml","form_type":"4"}},{"id":2633958,"issuer":{"id":2172,"kind":"organization","name":"10x Genomics, Inc.","symbol":"TXG"},"owners":[{"id":124251,"kind":"person","name":"CRUTCHFIELD BRADFORD","position":1,"cik":"0001246406","reported_name":"CRUTCHFIELD BRADFORD","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Commercial Officer"}}],"security":"Class A Common Stock","published_at":"2021-07-14T16:42:29.000Z","date":"2021-07-12","kind":"sale","acquired":false,"shares":500,"price":189.364,"value":94682.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The option exercise and sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan entered into by the Reporting Person."},{"field":"price","element":"transactionPricePerShare","label":"F7","text":"This transaction was executed in multiple trades at prices ranging from $189.07 to $189.75. The price reported above reflects the weighted average sale price. The Reporting Person undertakes to provide upon request by the staff of the Securities and Exchange Commission, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate sale price."}],"balance_after":44506,"source":{"system":"sec-edgar","filing":"0001209191-21-046677","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/1246406/000120919121046677/doc4.xml","form_type":"4"}},{"id":2633957,"issuer":{"id":2172,"kind":"organization","name":"10x Genomics, Inc.","symbol":"TXG"},"owners":[{"id":124251,"kind":"person","name":"CRUTCHFIELD BRADFORD","position":1,"cik":"0001246406","reported_name":"CRUTCHFIELD BRADFORD","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Commercial Officer"}}],"security":"Class A Common Stock","published_at":"2021-07-14T16:42:29.000Z","date":"2021-07-12","kind":"sale","acquired":false,"shares":1512,"price":188.3153,"value":284732.7336,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The option exercise and sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan entered into by the Reporting Person."},{"field":"price","element":"transactionPricePerShare","label":"F6","text":"This transaction was executed in multiple trades at prices ranging from $188.015 to $188.945. The price reported above reflects the weighted average sale price. The Reporting Person undertakes to provide upon request by the staff of the Securities and Exchange Commission, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate sale price."}],"balance_after":45006,"source":{"system":"sec-edgar","filing":"0001209191-21-046677","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1246406/000120919121046677/doc4.xml","form_type":"4"}},{"id":2633956,"issuer":{"id":2172,"kind":"organization","name":"10x Genomics, Inc.","symbol":"TXG"},"owners":[{"id":124251,"kind":"person","name":"CRUTCHFIELD BRADFORD","position":1,"cik":"0001246406","reported_name":"CRUTCHFIELD BRADFORD","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Commercial Officer"}}],"security":"Class A Common Stock","published_at":"2021-07-14T16:42:29.000Z","date":"2021-07-12","kind":"sale","acquired":false,"shares":3933,"price":187.306,"value":736674.498,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The option exercise and sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan entered into by the Reporting Person."},{"field":"price","element":"transactionPricePerShare","label":"F5","text":"This transaction was executed in multiple trades at prices ranging from $186.90 to $187.88. The price reported above reflects the weighted average sale price. The Reporting Person undertakes to provide upon request by the staff of the Securities and Exchange Commission, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate sale price."}],"balance_after":46518,"source":{"system":"sec-edgar","filing":"0001209191-21-046677","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1246406/000120919121046677/doc4.xml","form_type":"4"}},{"id":2633955,"issuer":{"id":2172,"kind":"organization","name":"10x Genomics, Inc.","symbol":"TXG"},"owners":[{"id":124251,"kind":"person","name":"CRUTCHFIELD BRADFORD","position":1,"cik":"0001246406","reported_name":"CRUTCHFIELD BRADFORD","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Commercial Officer"}}],"security":"Class A Common Stock","published_at":"2021-07-14T16:42:29.000Z","date":"2021-07-12","kind":"sale","acquired":false,"shares":4400,"price":185.8662,"value":817811.28,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The option exercise and sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan entered into by the Reporting Person."},{"field":"price","element":"transactionPricePerShare","label":"F4","text":"This transaction was executed in multiple trades at prices ranging from $185.47 to $186.41. The price reported above reflects the weighted average sale price. The Reporting Person undertakes to provide upon request by the staff of the Securities and Exchange Commission, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate sale price."}],"balance_after":50451,"source":{"system":"sec-edgar","filing":"0001209191-21-046677","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1246406/000120919121046677/doc4.xml","form_type":"4"}},{"id":2633954,"issuer":{"id":2172,"kind":"organization","name":"10x Genomics, Inc.","symbol":"TXG"},"owners":[{"id":124251,"kind":"person","name":"CRUTCHFIELD BRADFORD","position":1,"cik":"0001246406","reported_name":"CRUTCHFIELD BRADFORD","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Commercial Officer"}}],"security":"Class A Common Stock","published_at":"2021-07-14T16:42:29.000Z","date":"2021-07-12","kind":"sale","acquired":false,"shares":5755,"price":185.0734,"value":1065097.417,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The option exercise and sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan entered into by the Reporting Person."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"This transaction was executed in multiple trades at prices ranging from $184.47 to $185.44. The price reported above reflects the weighted average sale price. The Reporting Person undertakes to provide upon request by the staff of the Securities and Exchange Commission, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate sale price."}],"balance_after":54851,"source":{"system":"sec-edgar","filing":"0001209191-21-046677","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1246406/000120919121046677/doc4.xml","form_type":"4"}},{"id":2633953,"issuer":{"id":2172,"kind":"organization","name":"10x Genomics, Inc.","symbol":"TXG"},"owners":[{"id":124251,"kind":"person","name":"CRUTCHFIELD BRADFORD","position":1,"cik":"0001246406","reported_name":"CRUTCHFIELD BRADFORD","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Commercial Officer"}}],"security":"Class A Common Stock","published_at":"2021-07-14T16:42:29.000Z","date":"2021-07-12","kind":"exercise","acquired":true,"shares":17000,"price":1.16,"value":19720.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The option exercise and sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan entered into by the Reporting Person."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Includes an aggregate of 344 shares previously acquired under the Issuer's 2019 Employee Stock Purchase Plan."}],"balance_after":60606,"source":{"system":"sec-edgar","filing":"0001209191-21-046677","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1246406/000120919121046677/doc4.xml","form_type":"4"}},{"id":2665955,"issuer":{"id":2172,"kind":"organization","name":"10x Genomics, Inc.","symbol":"TXG"},"owners":[{"id":124251,"kind":"person","name":"CRUTCHFIELD BRADFORD","position":1,"cik":"0001246406","reported_name":"CRUTCHFIELD BRADFORD","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Commercial Officer"}}],"security":"Stock Option (right to buy)","published_at":"2021-06-16T18:03:03.000Z","date":"2021-06-14","kind":"exercise","acquired":false,"shares":17000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The option exercise and sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan entered into by the Reporting Person."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F8","text":"This option, originally for 800,000 shares, of which 272,000 shares have been exercised, vested as to one-fourth of the shares on February 2, 2018 and one forty-eighth of the shares subject to the option vest each month thereafter, subject to the Reporting Person continuing as a service provider through each such date."}],"balance_after":528000,"derivative":{"exercise_price":1.16,"expiration_date":"2027-02-03","underlying":"Class A Common Stock","underlying_shares":17000},"source":{"system":"sec-edgar","filing":"0001209191-21-041034","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":8,"url":"https://www.sec.gov/Archives/edgar/data/1246406/000120919121041034/doc4.xml","form_type":"4"}},{"id":2665954,"issuer":{"id":2172,"kind":"organization","name":"10x Genomics, Inc.","symbol":"TXG"},"owners":[{"id":124251,"kind":"person","name":"CRUTCHFIELD BRADFORD","position":1,"cik":"0001246406","reported_name":"CRUTCHFIELD BRADFORD","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Commercial Officer"}}],"security":"Class A Common Stock","published_at":"2021-06-16T18:03:03.000Z","date":"2021-06-14","kind":"sale","acquired":false,"shares":400,"price":193.64,"value":77456.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The option exercise and sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan entered into by the Reporting Person."},{"field":"price","element":"transactionPricePerShare","label":"F7","text":"This transaction was executed in multiple trades at prices ranging from $193.61 to $193.69. The price reported above reflects the weighted average sale price. The Reporting Person undertakes to provide upon request by the staff of the Securities and Exchange Commission, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate sale price."}],"balance_after":43262,"source":{"system":"sec-edgar","filing":"0001209191-21-041034","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":7,"url":"https://www.sec.gov/Archives/edgar/data/1246406/000120919121041034/doc4.xml","form_type":"4"}},{"id":2665953,"issuer":{"id":2172,"kind":"organization","name":"10x Genomics, Inc.","symbol":"TXG"},"owners":[{"id":124251,"kind":"person","name":"CRUTCHFIELD BRADFORD","position":1,"cik":"0001246406","reported_name":"CRUTCHFIELD BRADFORD","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Commercial Officer"}}],"security":"Class A Common Stock","published_at":"2021-06-16T18:03:03.000Z","date":"2021-06-14","kind":"sale","acquired":false,"shares":5100,"price":192.9662,"value":984127.62,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The option exercise and sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan entered into by the Reporting Person."},{"field":"price","element":"transactionPricePerShare","label":"F6","text":"This transaction was executed in multiple trades at prices ranging from $192.55 to $193.53. The price reported above reflects the weighted average sale price. The Reporting Person undertakes to provide upon request by the staff of the Securities and Exchange Commission, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate sale price."}],"balance_after":43662,"source":{"system":"sec-edgar","filing":"0001209191-21-041034","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/1246406/000120919121041034/doc4.xml","form_type":"4"}},{"id":2665952,"issuer":{"id":2172,"kind":"organization","name":"10x Genomics, Inc.","symbol":"TXG"},"owners":[{"id":124251,"kind":"person","name":"CRUTCHFIELD BRADFORD","position":1,"cik":"0001246406","reported_name":"CRUTCHFIELD BRADFORD","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Commercial Officer"}}],"security":"Class A Common Stock","published_at":"2021-06-16T18:03:03.000Z","date":"2021-06-14","kind":"sale","acquired":false,"shares":4500,"price":192.1189,"value":864535.05,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The option exercise and sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan entered into by the Reporting Person."},{"field":"price","element":"transactionPricePerShare","label":"F5","text":"This transaction was executed in multiple trades at prices ranging from $191.555 to $192.53. The price reported above reflects the weighted average sale price. The Reporting Person undertakes to provide upon request by the staff of the Securities and Exchange Commission, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate sale price."}],"balance_after":48762,"source":{"system":"sec-edgar","filing":"0001209191-21-041034","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1246406/000120919121041034/doc4.xml","form_type":"4"}},{"id":2665951,"issuer":{"id":2172,"kind":"organization","name":"10x Genomics, Inc.","symbol":"TXG"},"owners":[{"id":124251,"kind":"person","name":"CRUTCHFIELD BRADFORD","position":1,"cik":"0001246406","reported_name":"CRUTCHFIELD BRADFORD","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Commercial Officer"}}],"security":"Class A Common Stock","published_at":"2021-06-16T18:03:03.000Z","date":"2021-06-14","kind":"sale","acquired":false,"shares":3000,"price":191.1585,"value":573475.5,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The option exercise and sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan entered into by the Reporting Person."},{"field":"price","element":"transactionPricePerShare","label":"F4","text":"This transaction was executed in multiple trades at prices ranging from $190.555 to $191.54. The price reported above reflects the weighted average sale price. The Reporting Person undertakes to provide upon request by the staff of the Securities and Exchange Commission, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate sale price."}],"balance_after":53262,"source":{"system":"sec-edgar","filing":"0001209191-21-041034","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1246406/000120919121041034/doc4.xml","form_type":"4"}},{"id":2665950,"issuer":{"id":2172,"kind":"organization","name":"10x Genomics, Inc.","symbol":"TXG"},"owners":[{"id":124251,"kind":"person","name":"CRUTCHFIELD BRADFORD","position":1,"cik":"0001246406","reported_name":"CRUTCHFIELD BRADFORD","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Commercial Officer"}}],"security":"Class A Common Stock","published_at":"2021-06-16T18:03:03.000Z","date":"2021-06-14","kind":"sale","acquired":false,"shares":3084,"price":190.0113,"value":585994.8492,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The option exercise and sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan entered into by the Reporting Person."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"This transaction was executed in multiple trades at prices ranging from $189.49 to $190.48. The price reported above reflects the weighted average sale price. The Reporting Person undertakes to provide upon request by the staff of the Securities and Exchange Commission, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate sale price."}],"balance_after":56262,"source":{"system":"sec-edgar","filing":"0001209191-21-041034","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1246406/000120919121041034/doc4.xml","form_type":"4"}},{"id":2665949,"issuer":{"id":2172,"kind":"organization","name":"10x Genomics, Inc.","symbol":"TXG"},"owners":[{"id":124251,"kind":"person","name":"CRUTCHFIELD BRADFORD","position":1,"cik":"0001246406","reported_name":"CRUTCHFIELD BRADFORD","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Commercial Officer"}}],"security":"Class A Common Stock","published_at":"2021-06-16T18:03:03.000Z","date":"2021-06-14","kind":"sale","acquired":false,"shares":916,"price":189.0255,"value":173147.358,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The option exercise and sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan entered into by the Reporting Person."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"This transaction was executed in multiple trades at prices ranging from $188.49 to $189.47. The price reported above reflects the weighted average sale price. The Reporting Person undertakes to provide upon request by the staff of the Securities and Exchange Commission, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate sale price."}],"balance_after":59346,"source":{"system":"sec-edgar","filing":"0001209191-21-041034","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1246406/000120919121041034/doc4.xml","form_type":"4"}},{"id":2665948,"issuer":{"id":2172,"kind":"organization","name":"10x Genomics, Inc.","symbol":"TXG"},"owners":[{"id":124251,"kind":"person","name":"CRUTCHFIELD BRADFORD","position":1,"cik":"0001246406","reported_name":"CRUTCHFIELD BRADFORD","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Commercial Officer"}}],"security":"Class A Common Stock","published_at":"2021-06-16T18:03:03.000Z","date":"2021-06-14","kind":"exercise","acquired":true,"shares":17000,"price":1.16,"value":19720.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The option exercise and sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan entered into by the Reporting Person."}],"balance_after":60262,"source":{"system":"sec-edgar","filing":"0001209191-21-041034","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1246406/000120919121041034/doc4.xml","form_type":"4"}},{"id":2694854,"issuer":{"id":2172,"kind":"organization","name":"10x Genomics, Inc.","symbol":"TXG"},"owners":[{"id":124251,"kind":"person","name":"CRUTCHFIELD BRADFORD","position":1,"cik":"0001246406","reported_name":"CRUTCHFIELD BRADFORD","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Commercial Officer"}}],"security":"Stock Option (right to buy)","published_at":"2021-05-26T20:25:00.000Z","date":"2021-03-19","kind":"grant","acquired":true,"shares":22338,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F5","text":"This option, granted pursuant to the Issuer's 2019 Omnibus Incentive Plan, vests as to one forty-eighth of the shares on May 1, 2021 and each month thereafter, subject to the Reporting Person continuing as a service provider through each such date."}],"balance_after":22338,"derivative":{"exercise_price":177.76,"expiration_date":"2031-03-19","underlying":"Class A Common Stock","underlying_shares":22338},"source":{"system":"sec-edgar","filing":"0001209191-21-036100","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1246406/000120919121036100/doc4.xml","form_type":"4"}},{"id":2694853,"issuer":{"id":2172,"kind":"organization","name":"10x Genomics, Inc.","symbol":"TXG"},"owners":[{"id":124251,"kind":"person","name":"CRUTCHFIELD BRADFORD","position":1,"cik":"0001246406","reported_name":"CRUTCHFIELD BRADFORD","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Commercial Officer"}}],"security":"Class A Common Stock","published_at":"2021-05-26T20:25:00.000Z","date":"2021-05-24","kind":"sale","acquired":false,"shares":281,"price":162.6596,"value":45707.3476,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F3","text":"These shares were sold to cover tax withholding obligations in connection with the vesting of RSUs."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F4","text":"The number of shares beneficially owned following the reported transaction is as of May 24, 2021."}],"balance_after":43262,"source":{"system":"sec-edgar","filing":"0001209191-21-036100","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1246406/000120919121036100/doc4.xml","form_type":"4"}},{"id":2694852,"issuer":{"id":2172,"kind":"organization","name":"10x Genomics, Inc.","symbol":"TXG"},"owners":[{"id":124251,"kind":"person","name":"CRUTCHFIELD BRADFORD","position":1,"cik":"0001246406","reported_name":"CRUTCHFIELD BRADFORD","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Commercial Officer"}}],"security":"Class A Common Stock","published_at":"2021-05-26T20:25:00.000Z","date":"2021-03-19","kind":"grant","acquired":true,"shares":8935,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"These securities are restricted stock units (\"RSUs\"). Each RSU represents a contingent right to receive one share of Class A Common Stock. One-sixteenth of the RSUs shall vest on May 21, 2021 and on each three-month anniversary thereafter, subject to the Reporting Person continuing as a service provider through each such date."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"The number of shares beneficially owned following the reported transaction is as of March 19, 2021."}],"balance_after":43543,"source":{"system":"sec-edgar","filing":"0001209191-21-036100","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1246406/000120919121036100/doc4.xml","form_type":"4"}},{"id":2714241,"issuer":{"id":2172,"kind":"organization","name":"10x Genomics, Inc.","symbol":"TXG"},"owners":[{"id":124251,"kind":"person","name":"CRUTCHFIELD BRADFORD","position":1,"cik":"0001246406","reported_name":"CRUTCHFIELD BRADFORD","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Commercial Officer"}}],"security":"Stock Option (right to buy)","published_at":"2021-05-13T19:33:36.000Z","date":"2021-05-12","kind":"exercise","acquired":false,"shares":17000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The option exercise and sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan entered into by the Reporting Person."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F6","text":"This option, originally for 800,000 shares, of which 255,000 shares have been exercised, vested as to one-fourth of the shares on February 2, 2018 and one forty-eighth of the shares subject to the option vest each month thereafter, subject to the Reporting Person continuing as a service provider through each such date."}],"balance_after":545000,"derivative":{"exercise_price":1.16,"expiration_date":"2027-02-03","underlying":"Class A Common Stock","underlying_shares":17000},"source":{"system":"sec-edgar","filing":"0001209191-21-032476","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":7,"url":"https://www.sec.gov/Archives/edgar/data/1246406/000120919121032476/doc4.xml","form_type":"4"}},{"id":2714240,"issuer":{"id":2172,"kind":"organization","name":"10x Genomics, Inc.","symbol":"TXG"},"owners":[{"id":124251,"kind":"person","name":"CRUTCHFIELD BRADFORD","position":1,"cik":"0001246406","reported_name":"CRUTCHFIELD BRADFORD","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Commercial Officer"}}],"security":"Class A Common Stock","published_at":"2021-05-13T19:33:36.000Z","date":"2021-05-12","kind":"sale","acquired":false,"shares":100,"price":137.57,"value":13757.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The option exercise and sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan entered into by the Reporting Person."}],"balance_after":34608,"source":{"system":"sec-edgar","filing":"0001209191-21-032476","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/1246406/000120919121032476/doc4.xml","form_type":"4"}},{"id":2714239,"issuer":{"id":2172,"kind":"organization","name":"10x Genomics, Inc.","symbol":"TXG"},"owners":[{"id":124251,"kind":"person","name":"CRUTCHFIELD BRADFORD","position":1,"cik":"0001246406","reported_name":"CRUTCHFIELD BRADFORD","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Commercial Officer"}}],"security":"Class A Common Stock","published_at":"2021-05-13T19:33:36.000Z","date":"2021-05-12","kind":"sale","acquired":false,"shares":1200,"price":136.8033,"value":164163.96,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The option exercise and sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan entered into by the Reporting Person."},{"field":"price","element":"transactionPricePerShare","label":"F5","text":"This transaction was executed in multiple trades at prices ranging from $136.44 to $137.14. The price reported above reflects the weighted average sale price. The Reporting Person undertakes to provide upon request by the staff of the Securities and Exchange Commission, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate sale price."}],"balance_after":34708,"source":{"system":"sec-edgar","filing":"0001209191-21-032476","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1246406/000120919121032476/doc4.xml","form_type":"4"}},{"id":2714238,"issuer":{"id":2172,"kind":"organization","name":"10x Genomics, Inc.","symbol":"TXG"},"owners":[{"id":124251,"kind":"person","name":"CRUTCHFIELD BRADFORD","position":1,"cik":"0001246406","reported_name":"CRUTCHFIELD BRADFORD","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Commercial Officer"}}],"security":"Class A Common Stock","published_at":"2021-05-13T19:33:36.000Z","date":"2021-05-12","kind":"sale","acquired":false,"shares":2702,"price":135.7444,"value":366781.3688,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The option exercise and sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan entered into by the Reporting Person."},{"field":"price","element":"transactionPricePerShare","label":"F4","text":"This transaction was executed in multiple trades at prices ranging from $135.38 to $136.30. The price reported above reflects the weighted average sale price. The Reporting Person undertakes to provide upon request by the staff of the Securities and Exchange Commission, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate sale price."}],"balance_after":35908,"source":{"system":"sec-edgar","filing":"0001209191-21-032476","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1246406/000120919121032476/doc4.xml","form_type":"4"}},{"id":2714237,"issuer":{"id":2172,"kind":"organization","name":"10x Genomics, Inc.","symbol":"TXG"},"owners":[{"id":124251,"kind":"person","name":"CRUTCHFIELD BRADFORD","position":1,"cik":"0001246406","reported_name":"CRUTCHFIELD BRADFORD","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Commercial Officer"}}],"security":"Class A Common Stock","published_at":"2021-05-13T19:33:36.000Z","date":"2021-05-12","kind":"sale","acquired":false,"shares":7875,"price":134.6996,"value":1060759.35,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The option exercise and sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan entered into by the Reporting Person."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"This transaction was executed in multiple trades at prices ranging from $134.34 to $135.26. The price reported above reflects the weighted average sale price. The Reporting Person undertakes to provide upon request by the staff of the Securities and Exchange Commission, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate sale price."}],"balance_after":38610,"source":{"system":"sec-edgar","filing":"0001209191-21-032476","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1246406/000120919121032476/doc4.xml","form_type":"4"}},{"id":2714236,"issuer":{"id":2172,"kind":"organization","name":"10x Genomics, Inc.","symbol":"TXG"},"owners":[{"id":124251,"kind":"person","name":"CRUTCHFIELD BRADFORD","position":1,"cik":"0001246406","reported_name":"CRUTCHFIELD BRADFORD","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Commercial Officer"}}],"security":"Class A Common Stock","published_at":"2021-05-13T19:33:36.000Z","date":"2021-05-12","kind":"sale","acquired":false,"shares":5123,"price":133.8589,"value":685759.1447,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The option exercise and sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan entered into by the Reporting Person."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"This transaction was executed in multiple trades at prices ranging from $133.33 to $134.32. The price reported above reflects the weighted average sale price. The Reporting Person undertakes to provide upon request by the staff of the Securities and Exchange Commission, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate sale price."}],"balance_after":46485,"source":{"system":"sec-edgar","filing":"0001209191-21-032476","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1246406/000120919121032476/doc4.xml","form_type":"4"}},{"id":2714235,"issuer":{"id":2172,"kind":"organization","name":"10x Genomics, Inc.","symbol":"TXG"},"owners":[{"id":124251,"kind":"person","name":"CRUTCHFIELD BRADFORD","position":1,"cik":"0001246406","reported_name":"CRUTCHFIELD BRADFORD","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Commercial Officer"}}],"security":"Class A Common Stock","published_at":"2021-05-13T19:33:36.000Z","date":"2021-05-12","kind":"exercise","acquired":true,"shares":17000,"price":1.16,"value":19720.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The option exercise and sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan entered into by the Reporting Person."}],"balance_after":51608,"source":{"system":"sec-edgar","filing":"0001209191-21-032476","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1246406/000120919121032476/doc4.xml","form_type":"4"}},{"id":2750278,"issuer":{"id":2172,"kind":"organization","name":"10x Genomics, Inc.","symbol":"TXG"},"owners":[{"id":124251,"kind":"person","name":"CRUTCHFIELD BRADFORD","position":1,"cik":"0001246406","reported_name":"CRUTCHFIELD BRADFORD","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Commercial Officer"}}],"security":"Stock Option (right to buy)","published_at":"2021-04-13T16:40:34.000Z","date":"2021-04-12","kind":"exercise","acquired":false,"shares":17000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The option exercise and sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan entered into by the Reporting Person."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F13","text":"This option, originally for 800,000 shares, of which 238,000 shares have been exercised, vested as to one-fourth of the shares on February 2, 2018 and one forty-eighth of the shares subject to the option vest each month thereafter, subject to the Reporting Person continuing as a service provider through each such date."}],"balance_after":562000,"derivative":{"exercise_price":1.16,"expiration_date":"2027-02-03","underlying":"Class A Common Stock","underlying_shares":17000},"source":{"system":"sec-edgar","filing":"0001209191-21-026447","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":13,"url":"https://www.sec.gov/Archives/edgar/data/1246406/000120919121026447/doc4.xml","form_type":"4"}},{"id":2750277,"issuer":{"id":2172,"kind":"organization","name":"10x Genomics, Inc.","symbol":"TXG"},"owners":[{"id":124251,"kind":"person","name":"CRUTCHFIELD BRADFORD","position":1,"cik":"0001246406","reported_name":"CRUTCHFIELD BRADFORD","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Commercial Officer"}}],"security":"Class A Common Stock","published_at":"2021-04-13T16:40:34.000Z","date":"2021-04-12","kind":"sale","acquired":false,"shares":300,"price":192.1733,"value":57651.99,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The option exercise and sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan entered into by the Reporting Person."},{"field":"price","element":"transactionPricePerShare","label":"F12","text":"This transaction was executed in multiple trades at prices ranging from $192.00 to $192.52. The price reported above reflects the weighted average sale price. The Reporting Person undertakes to provide upon request by the staff of the Securities and Exchange Commission, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate sale price."}],"balance_after":34608,"source":{"system":"sec-edgar","filing":"0001209191-21-026447","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":12,"url":"https://www.sec.gov/Archives/edgar/data/1246406/000120919121026447/doc4.xml","form_type":"4"}},{"id":2750276,"issuer":{"id":2172,"kind":"organization","name":"10x Genomics, Inc.","symbol":"TXG"},"owners":[{"id":124251,"kind":"person","name":"CRUTCHFIELD BRADFORD","position":1,"cik":"0001246406","reported_name":"CRUTCHFIELD BRADFORD","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Commercial Officer"}}],"security":"Class A Common Stock","published_at":"2021-04-13T16:40:34.000Z","date":"2021-04-12","kind":"sale","acquired":false,"shares":1100,"price":190.3095,"value":209340.45,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The option exercise and sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan entered into by the Reporting Person."},{"field":"price","element":"transactionPricePerShare","label":"F11","text":"This transaction was executed in multiple trades at prices ranging from $190.01 to $191.68. The price reported above reflects the weighted average sale price. The Reporting Person undertakes to provide upon request by the staff of the Securities and Exchange Commission, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate sale price."}],"balance_after":34908,"source":{"system":"sec-edgar","filing":"0001209191-21-026447","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":11,"url":"https://www.sec.gov/Archives/edgar/data/1246406/000120919121026447/doc4.xml","form_type":"4"}},{"id":2750275,"issuer":{"id":2172,"kind":"organization","name":"10x Genomics, Inc.","symbol":"TXG"},"owners":[{"id":124251,"kind":"person","name":"CRUTCHFIELD BRADFORD","position":1,"cik":"0001246406","reported_name":"CRUTCHFIELD BRADFORD","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Commercial Officer"}}],"security":"Class A Common Stock","published_at":"2021-04-13T16:40:34.000Z","date":"2021-04-12","kind":"sale","acquired":false,"shares":1400,"price":189.3395,"value":265075.3,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The option exercise and sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan entered into by the Reporting Person."},{"field":"price","element":"transactionPricePerShare","label":"F10","text":"This transaction was executed in multiple trades at prices ranging from $188.98 to $189.90. The price reported above reflects the weighted average sale price. The Reporting Person undertakes to provide upon request by the staff of the Securities and Exchange Commission, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate sale price."}],"balance_after":36008,"source":{"system":"sec-edgar","filing":"0001209191-21-026447","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":10,"url":"https://www.sec.gov/Archives/edgar/data/1246406/000120919121026447/doc4.xml","form_type":"4"}},{"id":2750274,"issuer":{"id":2172,"kind":"organization","name":"10x Genomics, Inc.","symbol":"TXG"},"owners":[{"id":124251,"kind":"person","name":"CRUTCHFIELD BRADFORD","position":1,"cik":"0001246406","reported_name":"CRUTCHFIELD BRADFORD","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Commercial Officer"}}],"security":"Class A Common Stock","published_at":"2021-04-13T16:40:34.000Z","date":"2021-04-12","kind":"sale","acquired":false,"shares":2398,"price":188.3631,"value":451694.7138,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The option exercise and sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan entered into by the Reporting Person."},{"field":"price","element":"transactionPricePerShare","label":"F9","text":"This transaction was executed in multiple trades at prices ranging from $187.98 to $188.94. The price reported above reflects the weighted average sale price. The Reporting Person undertakes to provide upon request by the staff of the Securities and Exchange Commission, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate sale price."}],"balance_after":37408,"source":{"system":"sec-edgar","filing":"0001209191-21-026447","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":9,"url":"https://www.sec.gov/Archives/edgar/data/1246406/000120919121026447/doc4.xml","form_type":"4"}},{"id":2750273,"issuer":{"id":2172,"kind":"organization","name":"10x Genomics, Inc.","symbol":"TXG"},"owners":[{"id":124251,"kind":"person","name":"CRUTCHFIELD BRADFORD","position":1,"cik":"0001246406","reported_name":"CRUTCHFIELD BRADFORD","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Commercial Officer"}}],"security":"Class A Common Stock","published_at":"2021-04-13T16:40:34.000Z","date":"2021-04-12","kind":"sale","acquired":false,"shares":1996,"price":187.0991,"value":373449.8036,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The option exercise and sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan entered into by the Reporting Person."},{"field":"price","element":"transactionPricePerShare","label":"F8","text":"This transaction was executed in multiple trades at prices ranging from $186.76 to $187.59. The price reported above reflects the weighted average sale price. The Reporting Person undertakes to provide upon request by the staff of the Securities and Exchange Commission, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate sale price."}],"balance_after":39806,"source":{"system":"sec-edgar","filing":"0001209191-21-026447","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":8,"url":"https://www.sec.gov/Archives/edgar/data/1246406/000120919121026447/doc4.xml","form_type":"4"}},{"id":2750272,"issuer":{"id":2172,"kind":"organization","name":"10x Genomics, Inc.","symbol":"TXG"},"owners":[{"id":124251,"kind":"person","name":"CRUTCHFIELD BRADFORD","position":1,"cik":"0001246406","reported_name":"CRUTCHFIELD BRADFORD","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Commercial Officer"}}],"security":"Class A Common Stock","published_at":"2021-04-13T16:40:34.000Z","date":"2021-04-12","kind":"sale","acquired":false,"shares":2855,"price":186.3085,"value":531910.7675,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The option exercise and sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan entered into by the Reporting Person."},{"field":"price","element":"transactionPricePerShare","label":"F7","text":"This transaction was executed in multiple trades at prices ranging from $185.755 to $186.75. The price reported above reflects the weighted average sale price. The Reporting Person undertakes to provide upon request by the staff of the Securities and Exchange Commission, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate sale price."}],"balance_after":41802,"source":{"system":"sec-edgar","filing":"0001209191-21-026447","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":7,"url":"https://www.sec.gov/Archives/edgar/data/1246406/000120919121026447/doc4.xml","form_type":"4"}}],"next_cursor":"2021-04-13T16:40:34.000000Z,2750272"}